Project ID: D2016-48
IP Status: US Patent #11142739
Technology Summary: Bioreactor systems are a vital cue in the process of 3D tissue engineering and the formation of tissue contracts. Bioreactors capable of stretching three-dimensional (3D) cellular constructs are considered to be good biomimetic models due to their ability to mimic the complexities of the cellular microenvironment along with mechanical cues. However, commercially available strain bioreactors typically lead to non –homogenous strain distribution within the collagen construct where the strain experienced by the cell inside the construct vary significantly based on their spatial location. Thus, there is a persistent demand for uniaxial tensile strain bioreactors that can produce enlarged area of homogenous strain distribution within 3D cellular constructs along with the minimal risk of construct disintegration. Currently, cosmetic companies can generate about 20 skin care cosmetic formulations in a week, but due to limitations of current skin cosmetic testing platforms, they can only test about 100 formulations in a year. Thus, there is also a great demand for creating an efficient, reliable, and custom surface area-sized human skin substitute cosmetic testing platform that is able to reduce the product development cycle time.
Invention Description: Researchers at the University of Toledo have developed a novel uniaxial tensile strain bioreactor to apply homogenous cyclic strains to 3D cell-encapsulated collagen constructs or ex vivo organs without compromising its structural integrity. The novel bioreactor uses silicone-based loading chambers specifically designed to effectively stretch the 3D collagen constructs without direct gripping of the constructs. It is easy to set up, operate, and maintain, and is compact enough to fit into a standard cell culture incubator.
Application:
Advantages:
Publications: